CHICAGO--(BUSINESS WIRE)--Veradigm ® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today the launch of its disease-specific cardiometabolic Clinical Data ...
Veradigm, formerly known as Allscripts, has partnered with HealthVerity to advance research and improve care for patients with cardiovascular disease and diabetes. Under the partnership, Veradigm will ...
CHICAGO--(BUSINESS WIRE)--Researchers from Veradigm ®, a leading provider of healthcare data and technology solutions, will present health economics and outcomes research (HEOR) data on Covid-19, ...
Registry to Enable Prospective Safety Study “DISCOVER-HCM” to Track Long-Term Safety and Effectiveness of Mavacamten in Patients with Symptomatic, Obstructive Hypertrophic Cardiomyopathy BRISBANE, ...
What looks to be a small wine fridge is tucked away inconspicuously in the corner of Veradigm’s 12th floor office in the Flatiron neighborhood of Manhattan. But rather than bottles of burgundy, the ...
Download this comprehensive analysis of over 53 million distinct cardiovascular patients from the Veradigm Network EHR database of de-identified real world data. You’ll gain access to a thorough ...
The American College of Cardiology, in collaboration with Amgen and Veradigm, today announced a new national study to transform care for acute coronary syndrome (ACS) patients at risk for future ...
With the introduction of seven new disease-specific registry datasets, Veradigm is enabling deep, targeted research to drive innovation and enhance real-world clinical insights Veradigm’s Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results